Tumour microenvironment: Laminin 332 in squamous-cell carcinoma

Nature Reviews Cancer

Volumn 7, Issue 5, 2007, Pages 370-380

  Marinkovich, M Peter ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6BETA4 INTEGRIN; ANTINEOPLASTIC AGENT; CELL SURFACE RECEPTOR; COLLAGEN TYPE 7; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; KALININ; LAMININ; LAMININ 111; LAMININ GAMMA2; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; SYNDECAN 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

AUTOCRINE EFFECT; BASEMENT MEMBRANE; BLISTER; CANCER INVASION; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; COLON CARCINOMA; DRUG SAFETY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESOPHAGUS CARCINOMA; HUMAN; LARYNX CARCINOMA; MEMBRANE BIOLOGY; MOLECULAR INTERACTION; MOUTH CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; COLLAGEN TYPE VII; HUMANS; LAMININ; MICE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 34247474890     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2089     Document Type: Review

References (105)

1. Miller, D. L. & Weinstock, M. A. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30, 774-778 (1994).
2. Czarnecki, D., Staples, M., Mar, A., Giles, G. & Meehan, C. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology 189, 52-54 (1994).
3. McGowan, K. A. & Marinkovich, M. P. Laminins and human disease. Microsc. Res. Tech. 51, 262-279 (2000).
4. Keene, D. R., Marinkovich, M. P. & Sakai, L. Y. Immunodissection of the connective tissue matrix in human skin. Microsc. Res. Tech. 38, 394-406 (1997).
5. Beauvais, D. M. & Rapraeger, A. C. Syndecans in tumor cell adhesion and signaling. Reprod. Biol. Endocrinol. 2, 3 (2004).
6. Guo, W. & Giancotti, F. G. Integrin signalling during tumour progression. Nature Rev. Mol. Cell Biol. 5, 816-826 (2004).
7. Hornebeck, W. & Maquart, F. X. Proteolyzed matrix as a template for the regulation of tumor progression. Biomed. Pharmacother. 57, 223-230 (2003).
8. Mareel, M. & Leroy, A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376 (2003).
9. Liotta, L. A., Rao, C. N. & Wewer, U. M. Biochemical interactions of tumor cells with basement membrane. Ann. Rev. Biochem. 55, 1037-1057 (1986).
10. Liotta, L. A. et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68 (1980).
11. Sasaki, T., Fassler, R. & Hohenester, E. Laminin: the crux of basement membrane assembly. J. Cell Biol. 164, 959-963 (2004).
12. Ryan, M. C. et al. The functions of laminins: lessons from in vivo studies. Matrix Biol. 15, 369-381 (1996).
13. Marinkovich, M. P. et al. The basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab. Invest. 69, 295-299 (1993).
14. Meneguzzi, G. et al. Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp. Dermatol. 1, 221-229 (1992).
15. Pulkkinen, L. et al. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 24, 357-360 (1994).
16. Aberdam, D. et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nature Genet. 6, 299-304 (1994).
17. Martin, G. R. & Timpl, R. Laminin and other basement membrane components. Annu. Rev. Cell Biol. 3, 57-85 (1987).
18. Kallunki, P. et al. A truncated laminin chain homologous to the B2 chain: structure, spacial expression, and chromosomal assignment. J. Cell Biol. 119, 679-694 (1992). Identification of laminin 332 as a member of the laminin family.
19. Mizushima, H. et al. Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J. Biochem. (Tokyo) 120, 1196-1202 (1996).
20. Pyke, C. et al. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 55, 4132-4139 (1995). Early extensive survey of laminin 332 in human carcinomas.
21. Tani, T. et al. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am. J. Pathol. 151, 1289-1302 (1997).
22. Berndt, A., Hyckel, P., Könneker, A., Katenkamp, D. & Kosmehl, H. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. Clues from an in vitro invasion model. Invasion Metastasis 17, 251-258 (1997).
23. Orian-Rousseau, V. et al. Human colonic cancer cells synthesize and adhere to laminin-5. Their adhesion to laminin-5 involves multiple receptors among which is integrin alpha2beta1. J. Cell Sci. 111, 1993-2004 (1998).
24. Skyldberg, B. et al. Laminin-5 as a marker of invasiveness in cervical lesions. J. Natl Cancer Inst. 91, 1882-1887 (1999).
25. Ono, Y. et al. Clinocopathologic significance of laminin-5 ?2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 85, 2315-2321 (1999).
26. Lohi, J. et al. Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for α3β1 integrin. APMIS 108, 161-172 (2000).
27. Nordemar, S. et al. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx. Anticancer Res. 21, 509-512 (2001).
28. Lenander, C. et al. Laminin-5 gamma 2 chain expression correlates with unfavorable prognosis in colon carcinomas. Anal. Cell. Pathol. 22, 201-209 (2001).
29. Calaluce, R. et al. Laminin-5-mediated gene expression in human prostate carcinoma cells. Mol. Carcinog. 30, 119-129 (2001).
30. Nordemar, S., Hogmo, A., Lindholm, J., Auer, G. & Munck-Wikland, E. Laminin-5 gamma 2: a marker to identify oral mucosal lesions at risk for tumor development? Anticancer Res. 23, 4985-4989 (2003).
31. Giannelli, G., Fransvea, E., Bergamini, C., Marinosci, F. & Antonaci, S. Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. Clin. Cancer Res. 9, 3684-3691 (2003).
32. Yamamoto, H., Itoh, F., Iku, S., Hosokawa, M. & Imai, K. Expression of the γ (2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin. Cancer Res. 7, 896-900 (2001).
33. Nordstrom, B. et al. Laminin-5 gamma 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract. Int. J. Gynecol. Cancer 12, 105-109 (2002).
34. Giannelli, G. & Antonaci, S. Biological and clinical relevance of Laminin-5 in cancer. Clin. Exp. Metastasis 18, 439-443 (2000).
35. Katayama, M., Sanzen, N., Funakoshi, A. & Sekiguchi, K. Laminin γ2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res. 63, 222-229 (2003).
36. Shinto, E. et al. Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab. Invest. 85, 257-266 (2005).
37. Savoia, P., Trusolino, L., Pepino, E. & Marchisio, P. C. Expression and topography of integrins and basement membrane proteins in epidermal carcinomas: basal but not squamous cell carcinomas display loss of alpha 6 beta 4 and BM-600/nicein. J. Invest. Dermatol. 101, 352-358 (1993).
38. Martin, K. J. et al. Down-regulation of laminin-5 in breast carcinoma cells. Mol. Med. 4, 602-613 (1998).
39. Holler, E. Laminin isoform expression in breast tumors. Breast Cancer Res. 7, 166-167 (2005).
40. Hao, J. et al. Investigation into the mechanism of the loss of laminin 5 (α3β3γ2) expression in prostate cancer. Am. J. Pathol. 158, 1129-135. (2001).
41. Janes, S. M. & Watt, F. M. New roles for integrins in squamous-cell carcinoma. Nature Rev. Cancer 3, 175-183 (2006).
42. Li, J. et al. Laminin-10 is crucial for hair morphogenesis. EMBO J. 22, 2400-2410 (2003).
43. Fan, H. & Khavari, P. A. Sonic hedgehog opposes epithelial cell cycle arrest. J. Cell Biol. 147, 71-76 (1999).
44. Shaw, L. M. Tumor cell invasion assays. Methods Mol. Biol. 294, 97-105 (2005).
45. Malinda, K. M. In vivo matrigel migration and angiogenesis assays. Methods Mol. Med. 78, 329-335 (2003).
46. Mullen, P. The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts. Methods Mol. Med. 88, 287-292 (2004).
47. Ekblom, P., Lonai, P. & Talts, J. F. Expression and biological role of laminin-1. Matrix Biol. 22, 35-47 (2003).
48. Rousselle, P., Lunstrum, G. P., Keene, D. R. & Burgeson, R. E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell Biol. 114, 567-576 (1991). Characterization of the role of laminin 332 in epidermal adhesion.
49. Carter, W. G., Ryan, M. C. & Gahr, P. J. Epiligrin, a new cell adhesion ligand for integrin-3-1 in epithelial basement membranes. Cell 65, 559-610 (1991). Characterization of laminin 332 integrin specificity.
50. Carter, W. G., Kaur, P., Gil, S. G., Gahr, P. J. & Wayner, E. A. Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J. Cell Biol. 111, 3141-3154 (1990).
51. Hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration. Nature Rev. Cancer 2, 91-100 (2002).
52. Nievers, M. G., Schaapveld, R. Q. & Sonnenberg, A. Biology and function of hemidesmosomes. Matrix Biol. 18, 5-17 (1999).
53. Litjens, S. H., de Pereda, J. M. & Sonnenberg, A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 16, 376-383 (2006).
54. Geuijen, C. A. & Sonnenberg, A. Dynamics of the α6β4 Integrin in keratinocytes. Mol. Biol. Cell 13, 3845-3858 (2002).
55. Salo, S. et al. Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migration-related element in the γ2 chain gene (LAMC2) with activity in transgenic mice. Matrix Biol. 18, 197-210 (1999).
56. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G. & Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228 (1997). Shows the association between laminin 332 processing and carcinoma cell migration.
57. Zhang, K. & Kramer, R. H. Laminin 5 deposition promotes keratinocyte motility. Exp. Cell Res. 227, 309-322 (1996).
58. Miyazaki, K., Kikkawa, Y., Nakamura, A., Yasumitsu, H. & Umeda, M. A large cell-adhesive scatter factor secreted by human gastric carcinoma cells. Proc. Natl Acad. Sci. USA 90, 11767-1171 (1993). Demonstration of the role of laminin 332 in tumour-cell migration.
59. Kariya, Y. & Miyazaki, K. The basement membrane protein laminin-5 acts as a soluble cell motility factor. Exp. Cell Res. 297, 508-520 (2004).
60. Nguyen, B. P., Gil, S. G. & Carter, W. G. Deposition of laminin 5 by keratinocytes regulates integrin adhesion and signaling. J. Biol. Chem. 275, 31896-31907 (2000).
61. Nguyen, B. P., Ren, X. D., Schwartz, M. A. & Carter, W. G. Ligation of integrin α3β1 by laminin 5 at the wound edge activates Rho-dependent adhesion of leading keratinocytes on collagen. J. Biol. Chem. 276, 43860-43870 (2001).
62. Zhou, H. & Kramer, R. H. Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1. J. Biol. Chem. 280, 10624-10635 (2005).
63. Russell, A. J. et al. Alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. J. Cell Sci. 116, 3543-3556 (2003).
64. Pullar, C. E. et al. β4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol. Biol. Cell 17, 4925-4935 (2006).
65. Sehgal, B. U. et al. Integrin β4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J. Biol. Chem. 46, 35487-35498 (2006).
66. Zahir, N. et al. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors. J. Cell Biol. 163, 1397-1407 (2003).
67. Hamelers, I. H. et al. The Rac activator Tiam1 is required for α3β1-mediated laminin-5 deposition, cell spreading, and cell migration. J. Cell Biol. 171, 871-881 (2005).
68. Malliri, A. et al. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417, 867-871 (2002).
69. Danen, E. H. et al. Integrins control motile strategy through a Rho-cofilin pathway. J. Cell Biol. 169, 515-526 (2005).
70. Marinkovich, M. P., Lunstrum, G. P. & Burgeson, R. E. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J. Biol. Chem. 267, 17900-17906 (1992). Characterization of the proteolytic processing of laminin 332.
71. Amano, S. et al. Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ 2 chain. J. Biol. Chem. 275, 22728-22735 (2000).
72. Gerecke, D. R., Gordon, M. K., Wagman, W. W., Champliaud, M. F. & Burgeson, R. E. in Extracellular matrix assembly and structure (eds Mecham, R. P., Birk, D. E. & Yurchenko, P. D.) 417-439 (Academic Press, San Diego, USA, 1994).
73. Schenk, S. et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161, 197-209 (2003).
74. Decline, F. & Rousselle, P. Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 γ2 chain. J. Cell Sci. 114, 811-823 (2001).
75. Gagnoux-Palacios, L. et al. The short arm of the laminin γ2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J. Cell Biol. 153, 835-850. (2001).
76. Sigle, R. O. et al. Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5. J. Cell Sci. 117, 4481-4494 (2004).
77. Dajee, M. et al. NFκB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639-643 (2003). Demonstration of the requirement for laminin 332 and α6β4 integrin in human SCC tumours.
78. Waterman, E. A. et al. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3 kinase activation. Cancer Res. (in the press 2007).
79. Nakashima, Y., Kariya, Y., Yasuda, C. & Miyazaki, K. Regulation of cell adhesion and type VII collagen binding by the β3 chain short arm of laminin-5: effect of its proteolytic cleavage. J. Biochem. (Tokyo) 138, 539-552 (2005).
80. McGrath, J. A., Schofield, O. M., Mayou, B. J., McKee, P. H. & Eady, R. A. Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J. Cut. Pathol. 19, 116-123 (1992).
81. Newman, C., Wagner, R. F., Jr., Tyring, S. K. & Spigel, G. T. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous alignancies. J. Dermatol. Surg. Oncol. 18, 301-305 (1992).
82. Ortiz-Urda, S. et al. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307, 1773-1776 (2005). Demonstration of collagen VII requirement in human SCC tumours.
83. Guo, W. et al. β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126, 489-502 (2006).
84. Trusolino, L., Bertotti, A. & Comoglio, P. M. A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth. Cell 5, 643-654 (2001).
85. Okamoto, O. et al. Normal human keratinocytes bind to the α3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1. J. Biol. Chem. 278, 44168-44177 (2003).
86. Tsubota, Y. et al. Isolation and activity of proteolytic fragment of laminin-5 α3 chain. Biochem. Biophys. Res. Commun. 278, 614-620 (2000).
87. Veitch, D. P. et al. Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J. Biol. Chem. 278, 15661-15668 (2003).
88. Hintermann, E. & Quaranta, V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol. 23, 75-85 (2004).
89. Marinkovich, M. P., Keene, D. R., Rimberg, C. S. & Burgeson, R. E. Cellular origin of the dermalepidermal basement membrane. Dev. Dyn. 197, 255-267 (1993).
90. Timpl, R. et al. Laminin-a glycoprotein from basement membranes. J. Biol. Chem. 254, 9933-9937 (1979).
91. Takagi, J., Yang, Y., Liu, J. H., Wang, J. H. & Springer, T. A. Complex between nidogen and laminin fragments reveals a paradigmatic β-propeller interface. Nature 424, 969-974 (2003).
92. Cheng, Y. S., Champliaud, M. F., Burgeson, R. E., Marinkovich, M. P. & Yurchenco, P. D. Self-assembly of laminin isoforms. J. Biol. Chem. 272, 31525-31532 (1997).
93. Champliaud, M. F. et al. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J. Cell Biol. 132, 1189-1198 (1996).
94. Rousselle, P. et al. Laminin 5 binds the NC-1 domain of type VII collagen. J. Cell Biol. 138, 719-728 (1997).
95. Chen, M. et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. J. Biol. Chem. 272, 14516-14522 (1997).
96. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K. & Quaranta, V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148, 615-624 (2000).
97. Goldfinger, L. E., Stack, M. S. & Jones, J. C. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J. Cell Biol. 141, 255-265 (1998).
98. Timpl, R. et al. Structure and function of laminin LG modules. Matrix Biol. 19, 309-317. (2000).
99. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002).
100. Sung, U., O'Rear, J. J. & Yurchenco, P. D. Localization of heparin binding activity in recombinant laminin G domain. Eur. J. Biochem. 250, 138-143 (1997).
101. Henry, M. D. & Campbell, K. P. A role for dystroglycan in basement membrane assembly. Cell 95, 859-870 (1998).
102. Geerts, D. et al. Binding of integrin α6β4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J. Cell Biol. 147, 417-434 (1999).
103. Nievers, M. G., Kuikman, I., Geerts, D., Leigh, I. M. & Sonnenberg, A. Formation of hemidesmosome-like structures in the absence of ligand binding by the α6β4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the β4 integrin subunit. J. Cell Sci. 113, 963-973 (2000).
104. Sterk, L. M. et al. The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin α6β4 and may regulate the spatial organization of hemidesmosomes. J. Cell Biol. 149, 969-982 (2000).
105. Sterk, L. M. et al. Association of the tetraspanin CD151 with the laminin-binding integrins α3β1, α6β1, α6β4 and α7β1 in cells in culture and in vivo. J. Cell Sci. 115, 1161-1173 (2002).